Our results corroborate this hypothesis since hypertensive COVID-19 patients presented significantly higher s-Endocan and/or s-VCAM-1 concentrations than normotensives among severe and critical COVID-19 groups throughout the first week of hospitalization. This evidence concerns the gene VCAM1 and COVID-19.